ClinicalTrials.Veeva

Menu

Treatment for Specific Phobias in Children

Virginia Polytechnic Institute and State University logo

Virginia Polytechnic Institute and State University

Status and phase

Completed
Phase 2
Phase 1

Conditions

Phobic Disorders
Anxiety Disorders

Treatments

Behavioral: One-Session Treatment for Specific Phobias

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00051220
R01MH059308 (U.S. NIH Grant/Contract)
DSIR CT-S

Details and patient eligibility

About

This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.

Full description

Children with specific phobias may experience academic, social, and personal distress, as well as interference in day-to-day activities. One-Session Treatment has been found a rapid and effective treatment for adults with phobic disorders. However, its utility in the treatment of childhood phobia has not been examined.

Participants are randomly assigned to 1 of 3 groups: a one-session treatment group, an education/support group, and a waitlist control group. The one-session treatment group is directly exposed to a phobia object or situation during a 3-hour treatment session. In the education/support group, children are given information about fear and phobias and are taught how to deal with them through workbook activities. Children who participate in the one-session treatment group or the education/support group are assessed 1 week post-treatment and again after 6 months. Participants with improved symptoms have a 1-year follow-up. Participants with phobias that persist at 6 months are encouraged to participate in alternative treatment. Waitlist control participants are assessed pre-treatment and 1 month post-treatment. Those who continue to have phobias at the 1-month assessment are randomly assigned to 1 of the 2 active treatments.

Enrollment

150 patients

Sex

All

Ages

7 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary diagnosis of specific phobia disorder

Exclusion criteria

  • Mental retardation
  • Developmental disabilities
  • Suicide threat

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems